Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC

NCT00923364 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

NIH

Sponsor class

Conditions

MDS
Immunodeficiency
GATA2

Interventions

DRUG: Cyclophosphamide (CTX, Cytoxan)
DRUG: Fludarabine(Fludara,Berlex Laboratories)
PROCEDURE: Total Body Irradiation (TBI)
PROCEDURE: Allogeneic Hematopoietic Stem Cell (HSC)
DRUG: Equine Anti-Thymocyte Globulin

Sponsor

National Cancer Institute (NCI)